Scarica l'app Stockscreener
0.00
100.00%
-2.0301
Precedente Chiudi:
$2.0301
Aprire:
$0
Volume 24 ore:
0
Relative Volume:
0.00
Capitalizzazione di mercato:
$35.38M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-100.00%
1M Prestazione:
-100.00%
6M Prestazione:
-100.00%
1 anno Prestazione:
-100.00%
Intervallo 1D:
$0.00
$0.00
Intervallo di 1 settimana:
$0.00
$0.00
Portata 52W:
$0.00
$4.74
Mural Oncology Plc Stock (MURA) Company Profile
Nome
Mural Oncology Plc
Settore
Industria
Telefono
353 1 905 8020
Indirizzo
10 EARLSFORT TERRACE, DUBLIN 2
Confronta MURA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MURA
Mural Oncology Plc
|
0.00 | 35.38M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Mural Oncology Plc Stock (MURA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-25 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2024-06-28 | Iniziato | Rodman & Renshaw | Buy |
| 2024-04-04 | Iniziato | Morgan Stanley | Overweight |
Mural Oncology Plc Borsa (MURA) Ultime notizie
Will Mural Oncology plc stock outperform value stocks2025 AllTime Highs & Low Risk Entry Point Guides - ulpravda.ru
Will Mural Oncology plc stock outperform Nasdaq indexQuarterly Risk Review & AI Powered Trade Plan Recommendations - ulpravda.ru
Is Mural Oncology plc stock positioned for digital transformationQuarterly Profit Report & Community Consensus Picks - ulpravda.ru
How Mural Oncology plc stock compares to growth peersDollar Strength & Breakout Confirmation Alerts - ulpravda.ru
Retail Trends: Is Mural Oncology plc stock positioned for digital transformationGlobal Markets & Daily Oversold Stock Bounce Ideas - ulpravda.ru
Net debt of Mural Oncology Plc – LS:A3EE4M - TradingView — Track All Markets
Will Mural Oncology plc stock benefit from automation2026 world cup usa national team semifinals goalkeepers pressing system group prediction breakdown - ulpravda.ru
Return on invested capital % of Mural Oncology Plc – BER:IELK2BOB - TradingView — Track All Markets
XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab - marketscreener.com
Drug royalties reshuffled as XOMA trades part of one for nine experimental drugs - Stock Titan
Net margin % of Mural Oncology Plc – BER:IELK2BOB - TradingView — Track All Markets
Current ratio of Mural Oncology Plc – BER:IELK2BOB - TradingView — Track All Markets
Mural Oncology Plc Earnings and Revenue – BER:IELK2BOB - TradingView — Track All Markets
Mural Oncology Plc Statistics – BER:IELK2BOB - TradingView — Track All Markets
Mural Oncology Plc Cash Flow – BER:IELK2BOB - TradingView — Track All Markets
MURA SEC FilingsMural Oncology PLC 10-K, 10-Q, 8-K Forms - Stock Titan
Mural Oncology Plc Balance Sheet – BER:IELK2BOB - TradingView — Track All Markets
Mural Oncology Plc Dividends – BER:IELK2BOB - TradingView — Track All Markets
Entry Recap: How Mural Oncology plc stock reacts to oil prices2025 Pullback Review & Weekly Sector Rotation Insights - Улправда
Mural Oncology PLC (NASDAQ:MURA) Receives $12.00 Consensus Price Target from Brokerages - Defense World
How Mural Oncology plc stock reacts to oil pricesJuly 2025 Weekly Recap & Weekly High Potential Stock Alerts - Улправда
Market Recap: Will Mural Oncology plc stock benefit from automationJuly 2025 Review & Real-Time Stock Movement Alerts - Улправда
Generation Bio is latest Mass. biotech to be acquired by Xoma - The Business Journals
Xoma Navigates Clinical Setback with Strategic Acquisition - AD HOC NEWS
Xoma completes acquisition of Mural Oncology - MSN
Acorn Capital Advisors LLC Reduces Position in Mural Oncology PLC $MURA - Defense World
Mural Oncology shareholders approve acquisition by XRA 5 Corp. - MSN
Xoma Royalty Expands Portfolio Through Mural Oncology Acquisition - AD HOC NEWS
Mural Oncology Announces Sanction of the Scheme by the High Court - 富途牛牛
XOMA Royalty completes acquisition of Mural Oncology for $2.035 per share - Investing.com Nigeria
XOMA Royalty completes acquisition of Mural Oncology By Investing.com - Investing.com Nigeria
Xoma Completes Acquisition of Mural Oncology - TipRanks
Mural Oncology Announces Effectiveness of Scheme of Arrangement and Completion of Acquisition - Research Tree
Xoma Royalty announces closing of transaction to acquire Mural Oncology plc - marketscreener.com
XOMA Royalty Corporation Completes Acquisition of Mural Oncology plc Under Irish High Court Sanctioned Scheme - Quiver Quantitative
Mural Oncology Plc Completes Acquisition by XRA 5 Corp. - TipRanks
XOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology plc - Yahoo Finance
XOMA Royalty completes acquisition of Mural Oncology - Investing.com India
Mural Oncology plc Announces Effective Date of Scheme Arrangement for Acquisition by XOMA Royalty Corporation - Quiver Quantitative
Mural Oncology (Nasdaq: MURA) scheme with XOMA unit effective as Nasdaq listing ends - Stock Titan
Mural Oncology plc(NasdaqGM: MURA) dropped from S&P TMI Index - marketscreener.com
Mural Oncology plc (MURA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Mural Oncology plc(NasdaqGM: MURA) dropped from NASDAQ Composite Index - marketscreener.com
REGCitadel Group Mural Oncology PLCForm 8.3Mural Oncology plc - TradingView — Track All Markets
XOMA Royalty Corporation completed the acquisition of Mural Oncology plc from group of shareholders. - marketscreener.com
Irish court approves XOMA Royalty’s acquisition of Mural Oncology - Investing.com India
Irish court approves XOMA Royalty’s acquisition of Mural Oncology By Investing.com - Investing.com Australia
Mural Oncology plc Announces Court Approval of Scheme for Acquisition by XOMA Royalty Corporation's Subsidiary - Quiver Quantitative
Mural Oncology (Nasdaq: MURA) wins Irish court nod for XOMA deal, Nasdaq trading expected to end Dec. 4 - Stock Titan
Laser Focus WorldMural Oncology Announces Sanction of the Scheme by the High Court - FinancialContent
Mural Oncology (MURA) Stock Analysis Report | Financials & Insights - Benzinga
Mural Oncology Plc Azioni (MURA) Dati Finanziari
Non sono disponibili dati finanziari per Mural Oncology Plc (MURA). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):